All posts by: Michael Zand

About Michael Zand

Mesoblast lining up partners for stem cell trials – Herald Sun

Continue reading

2015-06-09 NEWS

The Australian Financial Review

Mesoblast lining up partners for stem cell trials
Herald Sun
Mesoblast’s 30-patient trial found an injection of the company’s MPC-300-IV product, an allogeneic mesenchymal precursor cell, was safe and improved organ function. The Melbourne-based company presented the results in poster form at the annual …
Mesoblast eyes pharma deals after diabetes trial successThe Australian Financial Review
Postive Trial Results Of Mesoblast Cell Therapy In Patients With Diabetes And GlobeNewswire (press release)

all 9 news articles »

Continue reading

2015-06-09 NEWS

The Australian Financial Review

Mesoblast lining up partners for stem cell trials
The Australian
Mesoblast’s 30-patient trial found an injection of the company’s MPC-300-IV product, an allogeneic mesenchymal precursor cell, was safe and improved organ function. The Melbourne-based company presented the results in poster form at the annual …
Mesoblast eyes pharma deals after diabetes trial successThe Australian Financial Review
Postive Trial Results Of Mesoblast Cell Therapy In Patients With Diabetes And GlobeNewswire (press release)

all 8 news articles »

Continue reading

2015-06-09 NEWS

The Australian Financial Review

Mesoblast lining up partners for stem cell trials
The Australian
Mesoblast’s 30-patient trial found an injection of the company’s MPC-300-IV product, an allogeneic mesenchymal precursor cell, was safe and improved organ function. The Melbourne-based company presented the results in poster form at the annual …
Mesoblast eyes pharma deals after diabetes trial successThe Australian Financial Review
Postive Trial Results Of Mesoblast Cell Therapy In Patients With Diabetes And GlobeNewswire (press release)

all 8 news articles »

Continue reading

2015-06-09 NEWS

The Australian Financial Review

Mesoblast lining up partners for stem cell trials
Business Spectator
Mesoblast’s 30-patient trial found an injection of the company’s MPC-300-IV product, an allogeneic mesenchymal precursor cell, was safe and improved organ function. The Melbourne-based company presented the results in poster form at the annual …
Mesoblast eyes pharma deals after diabetes trial successThe Australian Financial Review
Postive Trial Results Of Mesoblast Cell Therapy In Patients With Diabetes And GlobeNewswire (press release)

all 8 news articles »

Continue reading

2015-06-09 NEWS

NHL.com

Howe ‘comfortable’ after stemcell treatment: report
NHL.com
“Our dad continues to participate in a clinical trial where stem cells are being used in the treatment of a stroke,” son Murray Howe told The Hockey News. “We’d like to wait until the first phase of that clinical trial is complete before providing any

and more »

Continue reading

2015-06-09 NEWS

South China Morning Post (subscription)

Scientists swoon over stemcell breakthrough that may cure ‘untreatable’ injuries
South China Morning Post (subscription)
“This technology could cure (recently retired Chinese hurdler) Liu Xiang’s injury,” said Hu Ping, a cell biologist with the Shanghai Institute for Biological Science at the Chinese Academy of Sciences. “It can generate enough stem cells to heal

and more »